- Home
- TAIT vs PHIO Comparison
TAIT vs PHIO Comparison
Compare TAIT & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAIT
- PHIO
- Stock Information
- Founded
- TAIT 1989
- PHIO 2011
- Country
- TAIT United States
- PHIO United States
- Employees
- TAIT N/A
- PHIO N/A
- Industry
- TAIT Electronic Components
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- TAIT Technology
- PHIO Health Care
- Exchange
- TAIT Nasdaq
- PHIO Nasdaq
- Market Cap
- TAIT 15.1M
- PHIO 12.1M
- IPO Year
- TAIT 1995
- PHIO N/A
- Fundamental
- Price
- TAIT $2.55
- PHIO $2.16
- Analyst Decision
- TAIT
- PHIO Strong Buy
- Analyst Count
- TAIT 0
- PHIO 3
- Target Price
- TAIT N/A
- PHIO $10.67
- AVG Volume (30 Days)
- TAIT 32.2K
- PHIO 96.2K
- Earning Date
- TAIT 11-13-2025
- PHIO 11-13-2025
- Dividend Yield
- TAIT 7.84%
- PHIO N/A
- EPS Growth
- TAIT N/A
- PHIO N/A
- EPS
- TAIT N/A
- PHIO N/A
- Revenue
- TAIT $4,203,000.00
- PHIO N/A
- Revenue This Year
- TAIT N/A
- PHIO N/A
- Revenue Next Year
- TAIT N/A
- PHIO N/A
- P/E Ratio
- TAIT N/A
- PHIO N/A
- Revenue Growth
- TAIT N/A
- PHIO N/A
- 52 Week Low
- TAIT $2.01
- PHIO $0.97
- 52 Week High
- TAIT $5.10
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- TAIT 52.82
- PHIO 47.42
- Support Level
- TAIT $2.39
- PHIO $2.09
- Resistance Level
- TAIT $2.72
- PHIO $2.17
- Average True Range (ATR)
- TAIT 0.14
- PHIO 0.10
- MACD
- TAIT -0.00
- PHIO -0.02
- Stochastic Oscillator
- TAIT 52.24
- PHIO 26.15
About TAIT Taitron Components Incorporated
Taitron Components Inc is a supplier of originally designed and manufactured (ODM) products that include value-added engineering and turn-key solutions. It focuses on providing original equipment manufacturers (OEMs) and contracts electronic manufacturers (CEMs) with ODM products for their multi-year turn-key projects and ODM electronic components. The company's product offerings range from discrete semiconductors to small electronic devices. The company also distributes brand-name electronic components with a vast inventory available on hand. Its Taiwan and China locations, provide support for inventory sourcing, purchases, and coordinating the manufacture of ODM Projects and ODM Components.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.